Showing results (1211-1220 of 1,566) with videos related to
Sort By:
Pageof 157
Asia-Pacific Journal of Clinical Oncology|June 8, 2020
Diagnostic accuracy of MR, CT, and ECT in the differentiation of neoplastic from nonneoplastic spine lesionsPeng Liu, Yun Liang, Chong Bian, et al.Asia-Pacific Journal of Clinical Oncology|May 4, 2021
Telmisartan attenuates human glioblastoma cells proliferation and oncogenicity by inducing the lipid oxidationYan Wang, Tengrui Zhang, Chen Li, et al.Asia-Pacific Journal of Clinical Oncology|June 8, 2020
Immune checkpoint inhibitor therapy for cancer patients infected with HIV: A systematic reviewLing Luo, Yan Xu, Taisheng LiAsia-Pacific Journal of Clinical Oncology|August 26, 2025
Oncology Rehabilitation in Australia: A National Survey UpdateAlly Lasscock, Nicholas F Taylor, Amy M DennettAsia-Pacific Journal of Clinical Oncology|April 30, 2020
Trifluridine/tipiracil: A practical guide to its use in the management of refractory metastatic colorectal cancer in AustraliaTimothy Price, Matthew Burge, Lorraine Chantrill, et al.Asia-Pacific Journal of Clinical Oncology|April 15, 2020
A consensus statement on the use of biosimilar medicines in hematology in AustraliaGareth P Gregory, Christine Carrington, Chan Y Cheah, et al.Asia-Pacific Journal of Clinical Oncology|September 14, 2022
Safety of AS04-HPV-16/18 vaccine in Chinese women aged 26 years and older and long-term protective effect in women vaccinated at age 18-25 years: A 10-year follow-up studyFanghui Zhao, Archana Jastorff, Ying Hong, et al.Asia-Pacific Journal of Clinical Oncology|September 17, 2022
What affects the public healthcare costs of breast cancer in New Zealand?Chunhuan Lao, Mohana Mondal, Marion Kuper-Hommel, et al.Asia-Pacific Journal of Clinical Oncology|September 10, 2022
Arthralgia induced by endocrine therapy with or without cyclin-dependent kinase 4/6 inhibitors in breast cancer: A systematic review and meta-analysisDaiki Takatsuka, Masataka Sawaki, Masaya Hattori, et al.Asia-Pacific Journal of Clinical Oncology|September 10, 2022
Potential benefit of dose-escalated stereotactic body radiation therapy using CyberKnife for early-stage primary lung cancerShou Watanabe, Hideya Yamazaki, Takuya Kimoto, et al.Pageof 157